Dr. Mohamed K. Khan is an Attending Physician, the Director of Basic and Translational Radiation Research, co-director and founder of the NanoBiotechnology Center at RPCI, and the Residency Program Director in the Department of Radiation Medicine. He also serves as Associate Professor in the Department of Radiation Medicine at the University at Buffalo.
Dr. Khans research focuses on tumor angiogenesis, nanotechnology, and radiotherapy.
The Presidential Symposium session I am speaking at is Thinking Small: The Future of Nanoimaging and Nanotherapy. My primary research is using nanotechnology to repair the central nervous system. I will be speaking about using a 7 Tesla fMRI to successfully detect axons in the optic tract of hamsters before, during and after regeneration in a chronic injury treatment model. We hope to one day be able to write an individual prescription for a custom-tailored regeneration therapy for traumatic brain injury (TBI) and stroke.
I am Associate Editor/Neurology of the journal Nanomedicine: Nanotechnology, Biology and Medicine. In the past 3 years I have published 12 papers in the field of nanomedicine and delivered 53 invited lectures worldwide.
I have given approximately 20 national and international presentations on this work in the past 2 years. I have NIH funding for this project and have published numerous papers in the field.